Could a common diabetes pill help dialysis patients keep their kidneys working longer?
NCT ID NCT05715814
First seen May 07, 2026 · Last updated May 07, 2026
Summary
This study tests whether a daily 25 mg dose of empagliflozin, a drug usually used for diabetes, is safe and helps preserve the small amount of kidney function that some people on peritoneal dialysis still have. Researchers will measure changes in kidney function over time and check for any side effects. The study involves 20 adults who produce at least 250 ml of urine per day and are on a stable dialysis routine.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY DYSFUNCTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Toronto General Hospital
RECRUITINGToronto, Ontario, M5G2N2, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.